AcuCort AB
Develops user-friendly drug formulations for severe and acute allergic reactions.
ACUC | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0009695927
- LEI:
- 54930087FR3VVW5SU676
- Country:
- Sweden
- Address:
- Scheeletorget 1, 223 81 Lund
- Website:
- https://www.acucort.se/en/
- Sector:
- Manufacturing
Description
AcuCort AB is a pharmaceutical company that develops and commercializes innovative drug formulations based on well-documented substances. The company's strategy focuses on creating user-friendly products that address significant medical needs and improve upon existing treatments. Its primary product is Zeqmelit®, a fast-dissolving oral film for placement on the tongue. Zeqmelit® contains the established cortisone substance dexamethasone and is intended for the treatment of severe and acute allergic reactions. The product's key benefit is its simple and rapid administration, providing an effective alternative to conventional delivery methods.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AcuCort AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AcuCort AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AcuCort AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-24 | Ebba Cecilia Fåhraeus | Other | Buy | 91,000 | 81,900.00 SEK |
Peer Companies
